Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation.

Matza LS, Phillips GA, Revicki DA, Ascher-Svanum H, Malley KG, Palsgrove AC, Faries DE, Stauffer V, Kinon BJ, Awad AG, Keefe RS, Naber D.

Patient Prefer Adherence. 2012;6:521-32. doi: 10.2147/PPA.S25635. Epub 2012 Jul 13.

2.

Testing for heterogeneity among the components of a binary composite outcome in a clinical trial.

Pogue J, Thabane L, Devereaux PJ, Yusuf S.

BMC Med Res Methodol. 2010 Jun 7;10:49. doi: 10.1186/1471-2288-10-49.

3.

The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial.

Penn DL, Keefe RS, Davis SM, Meyer PS, Perkins DO, Losardo D, Lieberman JA.

Schizophr Res. 2009 Nov;115(1):17-23. doi: 10.1016/j.schres.2009.08.016. Epub 2009 Sep 18.

4.

Results of phase 3 of the CATIE schizophrenia trial.

Stroup TS, Lieberman JA, McEvoy JP, Davis SM, Swartz MS, Keefe RS, Miller AL, Rosenheck RA, Hsiao JK; CATIE Investigators.

Schizophr Res. 2009 Jan;107(1):1-12. doi: 10.1016/j.schres.2008.10.011. Epub 2008 Nov 21.

5.

What CATIE found: results from the schizophrenia trial.

Swartz MS, Stroup TS, McEvoy JP, Davis SM, Rosenheck RA, Keefe RS, Hsiao JK, Lieberman JA.

Psychiatr Serv. 2008 May;59(5):500-6. doi: 10.1176/ps.2008.59.5.500.

Supplemental Content

Support Center